From Sample to Insight: Technologies Driving the Future of Precision Oncology Assays
• Automation-Compatible, Low-Touch Workflows Reagents and assay formats designed for open- deck or cartridge-based liquid handling systems enable walkaway workflows and reduce manual intervention. Single-use, pre-aliquoted reagents also simplify assay set setup, minimize handling errors, and support consistent, high-throughput performance.
• Integrated Quality Controls Built-in controls, such as internal amplification or extraction checks and multiplexed QC markers, ensure result validity, detect failure points early, and maintain confidence in clinical reporting without adding workflow complexity.
Translating Assay Innovation into Meaningful Patient Outcomes In precision oncology, diagnostic assays are a critical
that are intuitive to use, minimize the risk of error, and scale efficiently across a variety of operational settings. As assay complexity increases, alongside demand for higher throughput, faster turnaround and broader accessibility, workflow optimization becomes a critical engineering discipline. Assay
component of cancer care. They must integrate seamlessly into clinical decision-making, deliver results within actionable timeframes, and maintain analytical integrity across diverse laboratory condi- tions. Achieving this requires workflow architectures
Figure 2. Streamlined workflow with direct amplification protocol (blue), compared to standard workflow (green).
GENengnews.com | 33
Powered by FlippingBook